Status:
UNKNOWN
Ketamine Versus Magnesium Sulphate as Adjuvants for ESPB in Breast Cancer Surgery
Lead Sponsor:
Assiut University
Conditions:
Analgesia
Breast Cancer
Eligibility:
FEMALE
18-60 years
Phase:
PHASE2
Brief Summary
Our aim will be to compare the analgesic efficacy and safety of ketamine and magnesium sulphate as adjuvants to levobupivacaine in erector spinae plane block in modified radical mastectomy.
Detailed Description
The participating females will be randomly allocated using computer generated randomizer program (http://www.randomizer.org) into one of 3 groups. Group (C) / (I): 20 patients (control group): Patie...
Eligibility Criteria
Inclusion
- Age of 18 - 60 years.
- ASA grade I - II.
Exclusion
- Patient refusal. known allergy to the study drugs skin infection at site of needle puncture significant organ dysfunction Coagulopathy drug or alcohol abuse psychiatric illness that would interfere with perception and assessment of pain.
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04275661
Start Date
August 1 2020
End Date
April 1 2022
Last Update
April 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
south Egypt Cancer Institute Assiut University
Asyut, Egypt